266 related articles for article (PubMed ID: 31907561)
1. Hypoxia: a barricade to conquer the pancreatic cancer.
Tan Z; Xu J; Zhang B; Shi S; Yu X; Liang C
Cell Mol Life Sci; 2020 Aug; 77(16):3077-3083. PubMed ID: 31907561
[TBL] [Abstract][Full Text] [Related]
2. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
3. Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters.
Dauer P; Nomura A; Saluja A; Banerjee S
Pancreatology; 2017; 17(1):7-12. PubMed ID: 28034553
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer.
Shah VM; Sheppard BC; Sears RC; Alani AW
Cancer Lett; 2020 Nov; 492():63-70. PubMed ID: 32822815
[TBL] [Abstract][Full Text] [Related]
5. The role of hypoxia in pancreatic cancer: a potential therapeutic target?
Erkan M; Kurtoglu M; Kleeff J
Expert Rev Gastroenterol Hepatol; 2016; 10(3):301-16. PubMed ID: 26560854
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
Li W; Sun X
Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers.
Zhang H; Cao K; Xiang J; Zhang M; Zhu M; Xi Q
Cancer Lett; 2023 Sep; 571():216345. PubMed ID: 37558084
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.
Liu H; Ma Q; Xu Q; Lei J; Li X; Wang Z; Wu E
Curr Pharm Des; 2012; 18(17):2395-403. PubMed ID: 22372500
[TBL] [Abstract][Full Text] [Related]
10. A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.
Kawakami K; Hattori M; Inoue T; Maruyama Y; Ohkanda J; Kato N; Tongu M; Yamada T; Akimoto M; Takenaga K; Sassa T; Suzumiy J; Honma Y
Anticancer Agents Med Chem; 2012 Sep; 12(7):791-800. PubMed ID: 22263802
[TBL] [Abstract][Full Text] [Related]
11. Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.
Lohse I; Rasowski J; Cao P; Pintilie M; Do T; Tsao MS; Hill RP; Hedley DW
Oncotarget; 2016 Jun; 7(23):33571-80. PubMed ID: 27248663
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
14. RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment.
Chen S; Zhang J; Chen J; Wang Y; Zhou S; Huang L; Bai Y; Peng C; Shen B; Chen H; Tian Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):15. PubMed ID: 30630537
[TBL] [Abstract][Full Text] [Related]
15. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Li W; Cao L; Chen X; Lei J; Ma Q
Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic tumor microenvironment: Implications for cancer therapy.
Roy S; Kumaravel S; Sharma A; Duran CL; Bayless KJ; Chakraborty S
Exp Biol Med (Maywood); 2020 Jul; 245(13):1073-1086. PubMed ID: 32594767
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
Hao X; Ren Y; Feng M; Wang Q; Wang Y
Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis.
Ji RC
Cancer Lett; 2014 Apr; 346(1):6-16. PubMed ID: 24333723
[TBL] [Abstract][Full Text] [Related]
20. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
